MarketInOut Stock Screener Log In | Sign Up

Lasa Supergenerics Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/26/2026
Lasa Supergenerics Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization265.04 mln
Float30.54 mln

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-3.27
Reliable

Relative Strength

1 / 100
Severely lagging

Debt / Equity

0.20
Very low leverage

Pre-Tax Margin

-245%
Severely loss-making

ROE

-26.18
Deeply negative

Business Description

Founded in 2016 and headquartered in Ratnagiri, India, Lasa Supergenerics Limited develops and produces a wide range of active pharmaceutical ingredients used in both human and animal healthcare. The company manufactures specialty compounds including antiparasitic and antimicrobial substances, along with feed additives and therapeutic reagents. Its products are sold across domestic markets and exported internationally.

Key Fundamentals

EPS-0.80
ROE-26.18
RPS1.30
ROIC-18.42
ROA-20.66
Interest Cover-28.66
EBITDA, mln-90.32
EV / EBITDA-4.15
EV / EBIT-2.49
Revenue, mln63.56
EV / Revenue5.89

Quote Details

Last 5.03
Change -0.26 (-4.91%)
Open 5.03
Volume 1
Turnover 5.03
Average Volume 6,635

Financial Ratios

Pre-Tax Profit Margin-245
Current Ratio0.62
Price / Book0.57
Price / Tangible Book0.86
Price / Cash Flow95.09
Debt / Equity0.20
Price / Sales4.47

Financial Strength

Altman Z-Score-1.77
Piotroski F-Score 3 / 9
Beneish M-Score-3.27
Price to Intrinsic Value0.50
Shiller PE Ratio0.08

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -15.6% 6 / 100   
1 Month -27.1% 3 / 100   
2 Months -30.14% 8 / 100   
6 Months -34.51% 11 / 100   
1 Year -59.4% 5 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog